Concepedia
Statistics
Publications
13
Citations
716
H-Index
12
Active since
1997
Affiliations
Stanford University(Current)
University of California San Diego
Titan Pharmaceuticals (United States)
Emory University
National Institutes of Health
Anish Bhatnagar is an author at Stanford University specializing in medicine, radiology, and pharmacology.
Publications per year
1997–2023
Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer
Tony Reid, Frank H. Valone, William LiPera et al. · Lung Cancer · 2004 · 162 citations
Medicine, Medicinal Chemistry, Oncology +16
Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin
Ronald A. Peck, Jan Hewett, Matthew W. Harding et al. · Journal of Clinical Oncology · 2001 · 107 citations
Medicine, Oncology, Pharmacology +14
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Roland Hustinx, Robin J. Smith, François Bénard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 100 citations
Medicine, Nuclear Medicine, Radiology +12
Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging
Robert A. Campbell, Zechariah G. Franks, Anish Bhatnagar et al. · The Journal of Immunology · 2017 · 88 citations · Full text
Veterinary Medicine, Immunology, Pathobiology +16
Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.
Anish Bhatnagar, Phyllis R. Vezza, John A. Bryan et al. · PubMed · 1998 · 71 citations
Medicine, Nuclear Medicine, Radiology +17
1–5 of 13